作者
Pedram Keshavarz, Fereshteh Yazdanpanah, Faranak Rafiee, Malkhaz Mizandari
发表日期
2021/8/1
来源
Academic radiology
卷号
28
期号
8
页码范围
1058-1071
出版商
Elsevier
简介
Rationale and Objectives
Despite all the benefits and effectiveness of the coronavirus disease 2019 (COVID-19) vaccines mentioned in recent clinical trials, some post-vaccination side effects such as lymphadenopathy (LAP) were observed. The present study reviewed all studies with imaging findings presentation of LAP after COVID-19 vaccination.
Materials and Methods
We conducted a literature search in online databases, including Scopus, Medline (PubMed), Web of Science, Embase (Elsevier), Cochrane library, and Google Scholar.
Results
A total of 19 studies (68 cases), including 60 (88.2%) females and eight (11.8%) males with a presentation of LAP after COVID-19 vaccination, were reviewed. LAP was identified after first or second dosages of three types of COVID-19 vaccines, including Pfizer-BioNTech (n = 30, 44.1%), Moderna (n = 17, 25%), and Oxford-AstraZeneca (n = 1, 1.5%). In 20 (29.4 …
学术搜索中的文章
P Keshavarz, F Yazdanpanah, F Rafiee, M Mizandari - Academic radiology, 2021